These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2092 related items for PubMed ID: 19524257

  • 1. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H, Zhao K, Wang L, Zheng Y, Zhang G, Mai H, Han Y, Yang L, Guo S.
    J Surg Res; 2010 May 15; 160(2):315-24. PubMed ID: 19524257
    [Abstract] [Full Text] [Related]

  • 2. [Adenovirus-mediated CTLA4 immunoglobulin based conditioning for non-myeloablative allogeneic hematopoietic cell transplantation to induce tolerance to hind limb allografts in rats].
    Pan H, Wang L, Zhang XD, Mai HX, Liu D, Liu Y, Guo SZ.
    Zhonghua Wai Ke Za Zhi; 2009 Jun 15; 47(12):937-40. PubMed ID: 19781252
    [Abstract] [Full Text] [Related]

  • 3. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S, Salgar SK, Kurimoto Y, Yousem S, Pham SM.
    J Surg Res; 2008 May 15; 146(2):289-97. PubMed ID: 18314139
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J, Ko S, Kanehiro H, Kanokogi H, Nakajima Y.
    J Surg Res; 2006 Jun 15; 133(2):61-8. PubMed ID: 16376943
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM.
    Circulation; 1998 Nov 10; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [Abstract] [Full Text] [Related]

  • 8. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL, Zadach K, Nalesnik M, Ildstad ST.
    Transplantation; 1995 Nov 15; 60(9):971-80. PubMed ID: 7491703
    [Abstract] [Full Text] [Related]

  • 9. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD, Pham S, Li S, Aitouche A.
    Transplantation; 2003 Sep 27; 76(6):988-94. PubMed ID: 14508367
    [Abstract] [Full Text] [Related]

  • 10. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A, Nalesnik MA, Ishikawa T, Azhipa O, Demetris AJ, Murase N.
    Transplantation; 2003 May 15; 75(9):1575-81. PubMed ID: 12792518
    [Abstract] [Full Text] [Related]

  • 11. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Lin JY, Tsai FC, Wallace CG, Huang WC, Wei FC, Liao SK.
    J Surg Res; 2012 Nov 15; 178(1):487-93. PubMed ID: 22484382
    [Abstract] [Full Text] [Related]

  • 12. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
    Li S, Salgar SK, Thanikachalam M, Murdock AD, Gammie JS, Demetris AJ, Zeevi A, Pham SM.
    J Surg Res; 2006 Dec 15; 136(2):238-46. PubMed ID: 17046021
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y, Liu J, Xu C, Zhang W, Bai L, Li N, Liu Y, Wang Y, Su Y, Hu D.
    J Surg Res; 2011 Nov 15; 171(1):e123-31. PubMed ID: 21920556
    [Abstract] [Full Text] [Related]

  • 14. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY, Pelot M, Zhao G, Swenson K, Pearson D, Sykes M.
    Biol Blood Marrow Transplant; 2001 Nov 15; 7(12):646-55. PubMed ID: 11787527
    [Abstract] [Full Text] [Related]

  • 15. Rapamycin, mycophenolate mofetil, methylprednisolone, and cytotoxic T-lymphocyte-associated antigen 4 immunoglobulin-based conditioning regimen to induce partial tolerance to hind limb allografts without cytoreductive conditioning.
    Pan H, Wang L, Zhang X, Zhang G, Mai H, Han Y, Guo S.
    Transplant Proc; 2008 Jun 15; 40(5):1714-21. PubMed ID: 18589179
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
    Lin JY, Tsai FC, Wallace CG, Huang WC, Wei FC, Liao SK.
    J Surg Res; 2012 Dec 15; 178(2):974-81. PubMed ID: 22819314
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX, Fan LY, Wang Q.
    Eur Surg Res; 2011 Dec 15; 46(3):109-17. PubMed ID: 21242693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 105.